deltatrials
Completed NA INTERVENTIONAL 1-arm NCT02989623

Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA

A Pilot Phase I Open Label Study of Cu-64-TP3805 PET Imaging for Detection of Prostate Cancer in Men With Persistently Elevated PSA

Sponsor: National Cancer Institute (NCI)

Conditions Prostate Cancer
Interventions Copper Cu 64 TP3805 Positron Emission Tomography and Computed Tomography Scan
Updated 12 times since 2017 Last updated: Apr 22, 2025 Started: Sep 1, 2015 Primary completion: Apr 24, 2019 Completion: Apr 25, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Prostate Cancer and is currently completed. National Cancer Institute (NCI) leads this study, which shows 12 recorded versions since 2015 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Feb 2018 · 12 months · monthly snapshotRecruiting~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotRecruiting~Jun 2018 – ~May 2019 · 11 months · monthly snapshotRecruiting~May 2019 – ~Jul 2019 · 2 months · monthly snapshotRecruiting~Jul 2019 – ~Jan 2021 · 18 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshotCompleted~Apr 2025 – ~May 2025 · 30 days · monthly snapshotCompleted~May 2025 – ~Feb 2026 · 9 months · monthly snapshotCompleted~Feb 2026 – present · 5 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed NA

  2. May 2025 — Feb 2026 [monthly]

    Completed NA

  3. Apr 2025 — May 2025 [monthly]

    Completed NA

  4. Sep 2024 — Apr 2025 [monthly]

    Completed NA

  5. Jul 2024 — Sep 2024 [monthly]

    Completed NA

▶ Show 7 earlier versions

  1. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  2. Jul 2019 — Jan 2021 [monthly]

    Completed NA

    Status: Recruiting → Completed

  3. May 2019 — Jul 2019 [monthly]

    Recruiting NA

  4. Jun 2018 — May 2019 [monthly]

    Recruiting NA

  5. Feb 2018 — Jun 2018 [monthly]

    Recruiting NA

  6. Feb 2017 — Feb 2018 [monthly]

    Recruiting NA

    Phase: Phase 0 → NA

  7. Jan 2017 — Feb 2017 [monthly]

    Recruiting Phase 0

    First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute (NCI)
  • National Institutes of Health (NIH)
  • Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Data source: Thomas Jefferson University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations